Stock Comparison
GSK vs LLY
GlaxoSmithKline PLC ADR and Eli Lilly and Company side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$105.17B
$1.08T
P/E (TTM)
14.0
42.9
Forward P/E
22.1
31.1
Price/Sales
3.2
14.9
Price/Book
4.5
32.2
EV/EBITDA
9.4
28.8
Dividend Yield
3.43%
0.55%
Profitability
Net Margin
17.80%
35.00%
Operating Margin
36.30%
49.40%
Return on Equity
40.90%
107.50%
Return on Assets
10.00%
20.70%
Growth (YoY)
Revenue Growth
1.50%
55.50%
Earnings Growth
8.40%
169.90%
Price & Risk
Beta
0.3
0.5
52-Week High
$60.65
$1,215.76
52-Week Low
$34.17
$619.40
Analyst Target
$56.63
$1,222.62
Compare GSK and LLY your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.